TrialProstate cancer and prostatic diseases2012

Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial.

P-L Kellokumpu-Lehtinen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.